or more than 2.3 million people, were behind bars. 1 An estimated 10 million Americans are incar cerated each year. 2 With only 5% of the world's population, the United States has a quarter of the world's prisoners. No other coun try locks up more of its citizens.
For black Americans, especial ly men with no college educa tion, incarceration has become an alarmingly common life expe rience. By middle age, black men in the United States are more likely to have spent time in prison than to have graduated from col lege or joined the military, 3 and they are far more likely than whites to be sent to prison for drug offenses despite being no more likely than whites to use drugs. 3 Much of the increase in the prisoner census is a result of the "War on Drugs" and our coun try's failure to treat addiction and mental illness as medical condi tions. The natural history of these diseases often leads to behaviors that result in incarceration. The medical profession has the chance both to advocate for changes in the criminal justice system to re duce the number of people behind bars who would be better served in communitybased treatment and to capitalize on the tremen dous public health opportunities for diagnosing and treating dis ease and for linking patients to care after release. Deinstitutionalization of the mentally ill over the past 50 years and severe punishment for drug users starting in the 1970s have shifted the burden of care for ad diction and mental illness to jails and prisons. The largest facilities housing psychiatric patients in the United States are not hospitals but jails. More than half of inmates have symptoms of a psychiatric disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSMIV), and major depression and psy chotic disorders are four to eight times as prevalent among inmates as in the general populationyet only 22% of state prisoners and 7% of jail inmates receive mental health treatment while in carcerated. 4 The medical care that many inmates receive, in combination with a different environment, can be lifesaving. Yet correctional facilities are fundamentally de signed to confine and punish, not to treat disease. The harsh and socially isolating conditions in jail or prison often exacerbate mental illness, especially when inmates are placed under soli tary confinement, as is common O ver the past 40 years, the number of people in U.S. prisons has increased by more than 600% -an unprecedented expansion of the criminal justice system. On January 1, 2008, one of every 100 adults, in the "super maximum" facili ties that have proliferated exten sively in recent years.
Substance use and dependence are highly prevalent in the incar cerated population. More than 50% of inmates meet the DSMIV criteria for drug dependence or abuse, and 20% of state prison ers have a history of injection drug use. 4 Up to a third of all heroin users -approximately 200,000 -pass through the crim inal justice system annually. With growing numbers of drug users in correctional facilities, the prev alence of infectious diseases has increased correspondingly. As many as a quarter of all Ameri cans infected with HIV and one in three with hepatitis C pass through a correctional facility each year. 2 Chronic noninfec tious diseases are also dispropor tionately prevalent in correction al facilities (see table) .
The impact of incarceration extends far beyond the approxi mately 10 million people who are put behind bars each year.
In lowincome minority commu nities where a large portion of the male population is in correc tional facilities at any given time, incarceration delivers a devastat ing blow to stable relationships, resulting in risky sexual partner ships that lead to increased rates of sexually transmitted diseases and HIV transmission and may increase rates of unwanted preg nancy. The disproportionate in carceration of young black men is also associated with low wages and rising unemployment rates, which further exacerbate dispar ities in health. Because no coun try has ever incarcerated people at such high rates, the full extent of the social and public health consequences will not be known for years to come. Nearly all prisoners will even tually return to the community, and the postrelease period pre sents extraordinary risks to in dividuals and costs to society. In the 2 weeks after release, former inmates are 129 times more like ly to die from a drug overdose than members of the general pub lic and 12 times more likely to die of any cause. 5 Yet most released inmates lack medical insurance, and Medicaid benefits have often been terminated upon incarcera tion. 2 Although dischargeplan ning practices vary considerably, inmates are typically released with no more than a 2week sup ply of even crucial medications such as insulin and with no pri mary care followup, so the bur den of care falls predominantly on emergency rooms and is fi nanced primarily by the public sector. 2 Addressing the health needs of this vulnerable popula tion is thus not only an ethical imperative, but also of crucial importance from both a fiscal and a public health perspective.
Correctional facilities are a critical component of the public safety infrastructure, but many observers believe that the social and economic costs associated with the unprecedented expan sion of the U.S. correctional sys tem now far outweigh the bene fits. State correctional spending has increased by 300% since 1980, to $50 billion annually; it's now the fastestgrowing area of gov ernment spending after Medic aid. 1 In Rhode Island, the aver age cost in 2008 of incarcerating an inmate for 1 year was $41,346; for an inmate in a super maxi mum security setting, the cost jumps to $109,026 annually. Five states now spend more on cor rections than they do on higher education. 1 As alternatives to in carceration, addiction and men tal health treatment programs are more humane and costeffective and ultimately better address the underlying problems, but politi cal support for these approaches is crippled by policymakers' fear of being labeled "soft on crime." There are tremendous medi cal and public health opportuni ties that can be created by ad dressing the health care needs of prisoners and former prisoners. Perhaps foremost among these is that opened up by health care reform: the Affordable Care Act will permit most former prison ers to receive health insurance coverage, which will offer them greater access to muchneeded medical care. Such access could redirect many people with seri ous illnesses away from the re volving door of the criminal jus tice system, thereby improving overall public health in the com munities to which prisoners re turn and decreasing the costs as sociated with reincarceration due to untreated addiction and men tal illness. To achieve these gains, we will need to ensure linkages to medical homes that provide substanceuse and mental health treatment for reentering popula tions. Partnerships between cor rectional facilities and community health care providers -espe cially community health centers and academic medical centerscan capitalize on health gains made during incarceration and improve the continuity of care for former inmates during the critical postrelease period. The success of this effort will deter mine not only the health of re leased prisoners, but that of our society as a whole.
Locking up millions of people for drugrelated crimes has failed as a publicsafety strategy and has harmed public health in the communities to which these men and women return. A new evi dencebased approach is desper ately needed. We believe that in addition to capitalizing on the public health opportunities that incarceration presents, the medi cal community and policymakers must advocate for alternatives to imprisonment, drugpolicy reform, and increased public awareness of this crisis in order to reduce mass incarceration and its collateral consequences.
Disclosure forms provided by the authors are available with the full text of this arti cle at NEJM.org. DES was developed in 1938 and used widely, including as a supplement to cattle feed in the 1960s and in humans for symp tom relief from estrogendefi ciency states, postpartum lacta tion suppression, and treatment of prostate and breast cancer. De spite some evidence to the con trary, a 1948 study suggested that DES taken in early pregnancy pre vented miscarriage. 1 Over the subsequent two decades, and de spite mounting evidence of lack of efficacy, DES was commonly prescribed for that purpose. Ulti mately, however, it was acknowl edged to be ineffective in the pre vention of miscarriage. The exact number of offspring exposed to DES in utero is unknown but is thought to be several million.
The 
